[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 55 of about 55
1. Ruiz Clemente J, Ortiz Bish E, Gonzalez García J, Gómez Aldaz E, Ruiz Carmona E, Muñoz Borge E, Galera Ruiz H: [Papillary carcinoma of the thyroid metastatic to the parapharyngeal space]. Acta Otorrinolaringol Esp; 2005 Mar;56(3):135-7
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Papillary carcinoma of the thyroid metastatic to the parapharyngeal space].
  • [Transliterated title] Tumoración parafaríngea metastásica de carcinoma papilar de tiroides.
  • This is a case report of a papillary thyroid carcinoma metastatic to the parapharyngeal space, that presented with local obstructive symptoms (dysphagia and displacement of the ipsilateral tonsil).
  • [MeSH-major] Carcinoma, Papillary / secondary. Pharyngeal Neoplasms / secondary. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Throat Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15819522.001).
  • [ISSN] 0001-6519
  • [Journal-full-title] Acta otorrinolaringológica española
  • [ISO-abbreviation] Acta Otorrinolaringol Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 12
  •  go-up   go-down


2. Chowhan AK, Kinnera VS, Yootla M, Reddy MK: Cervical ectopic thymus masquerading as metastatic thyroid papillary carcinoma. Malays J Pathol; 2010 Jun;32(1):65-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cervical ectopic thymus masquerading as metastatic thyroid papillary carcinoma.
  • We report a 12-year-old female presenting with multinodular thyroid swelling since seven years of age.
  • FNAC revealed adenomatous goitre with suspicious cystic papillary neoplastic foci, for which she underwent total thyroidectomy along with excision of a nodular swelling near the lower pole of the right thyroid lobe which was per-operatively suspected to be a lymph node.
  • Histopathological examination revealed a follicular variant papillary carcinoma of the thyroid with background thyroiditis, and a nodule of ectopic thymic tissue.
  • [MeSH-major] Carcinoma, Papillary / complications. Lymphatic Metastasis / pathology. Thyroid Dysgenesis / complications. Thyroid Dysgenesis / pathology. Thyroid Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20614729.001).
  • [ISSN] 0126-8635
  • [Journal-full-title] The Malaysian journal of pathology
  • [ISO-abbreviation] Malays J Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Malaysia
  •  go-up   go-down


3. Polyzos SA, Anastasilakis AD, Iakovou IP, Partsalidou V: Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man. Arq Bras Endocrinol Metabol; 2010 Aug;54(6):578-82
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man.
  • Co-existence of primary hyperparathyroidism (PHPT) and non-medullary thyroid carcinoma has been previously reported in sporadic case reports and some surgical series, but the majority of cases concerned women with occult papillary carcinomas without cervical lymph node involvement.
  • We present a 71-year man with PHPT and multinodular goiter who was subjected to surgery for single parathyroid adenoma and was found to have synchronous multifocal papillary thyroid carcinoma (PTC) with cervical lymph node involvement.
  • Ultrasonography of both thyroid and parathyroid glands might be considered in patients with hyperparathyroidism.
  • [MeSH-major] Carcinoma, Papillary / secondary. Hyperparathyroidism, Primary / complications. Incidental Findings. Parathyroid Neoplasms / surgery. Thyroid Neoplasms / complications

  • Genetic Alliance. consumer health - Hyperparathyroidism, primary.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20857065.001).
  • [ISSN] 1677-9487
  • [Journal-full-title] Arquivos brasileiros de endocrinologia e metabologia
  • [ISO-abbreviation] Arq Bras Endocrinol Metabol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


Advertisement
4. Machado NO, Chopra PJ, Al Hamdani A: Papillary Carcinoma of the Thyroid Presenting Primarily as Cervical Lymphadenopathy: An approach to management. Sultan Qaboos Univ Med J; 2009 Dec;9(3):328-32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary Carcinoma of the Thyroid Presenting Primarily as Cervical Lymphadenopathy: An approach to management.
  • Papillary carcinoma of thyroid usually presents as a palpable thyroid mass.
  • Rarely, it presents solely as cervical lympadenopthy in the presence of an otherwise grossly normal thyroid gland.
  • We report here a middle-aged lady who presented with cervical lymphadenopathy which on fine needle aspiration cytology was confirmed as metastatic papillary thyroid carcinoma.
  • The thyroid gland was, however, normal on clinical examination and radiological investigations.
  • Neck exploration confirmed a grossly normal thyroid gland; however, the cervical lymph node was found to invade the internal jugular vein.
  • Histopathology confirmed metastasis in the lymph node and a 2mm sized microcarcinoma in the resected thyroid gland.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 1989 Sep-Oct;11(5):410-3 [2807881.001]
  • [Cites] Semin Oncol. 1987 Sep;14(3):315-32 [3306936.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1986 Jan;112(1):47-9 [3940513.001]
  • [Cites] Ann Surg. 1982 Sep;196(3):361-70 [7114941.001]
  • [Cites] Neuroimaging Clin N Am. 2008 Aug;18(3):445-61, vii [18656027.001]
  • [Cites] Radiographics. 2008 Nov-Dec;28(7):1869-86; discussion 1887 [19001645.001]
  • [Cites] Head Neck. 1990 Mar-Apr;12(2):114-7 [2312276.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):971-87 [19041826.001]
  • [Cites] Ann Surg. 1977 Feb;185(2):133-44 [319768.001]
  • [Cites] Arch Surg. 1980 Apr;115(4):394-8 [7362444.001]
  • [Cites] Jpn J Surg. 1984 Mar;14(2):118-21 [6748383.001]
  • [Cites] Clin Nucl Med. 2009 Jan;34(1):4-6 [19092372.001]
  • [Cites] AJR Am J Roentgenol. 2009 Jan;192(1):66-72 [19098181.001]
  • [Cites] Expert Rev Med Devices. 2008 Nov;5(6):747-58 [19025350.001]
  • (PMID = 21509319.001).
  • [ISSN] 2075-0528
  • [Journal-full-title] Sultan Qaboos University medical journal
  • [ISO-abbreviation] Sultan Qaboos Univ Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Oman
  • [Other-IDs] NLM/ PMC3074800
  • [Keywords] NOTNLM ; Carcinoma of thyroid / Case report / Lymphatic metastasis / Oman / Thyroidectomy
  •  go-up   go-down


5. Ikeda M, Tanaka K, Sonoo H, Miyake A, Yamamoto Y, Shiiki S, Nakashima K, Kurebayashi J: [Docetaxel administration for radioiodine-resistant patients with metastatic papillary thyroid carcinoma]. Gan To Kagaku Ryoho; 2007 Jun;34(6):933-6
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Docetaxel administration for radioiodine-resistant patients with metastatic papillary thyroid carcinoma].
  • We report three radioiodine-resistant patients with metastatic papillary thyroid carcinoma administered docetaxel.
  • Since no effective systemic treatment has been established for radioiodine-resistant patients with metastatic papillary thyroid carcinoma,docetaxel therapy was supposed to be a viable alternative for them.
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Carcinoma, Papillary / drug therapy. Taxoids / administration & dosage. Thyroid Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17565260.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Iodine Radioisotopes; 0 / Taxoids; 15H5577CQD / docetaxel; 9010-34-8 / Thyroglobulin
  •  go-up   go-down


6. Vassilatou E, Fisfis M, Morphopoulos G, Savva S, Voucouti E, Stefanoudaki K, Tzavara I: Papillary thyroid carcinoma producing granulocyte-macrophage colony-stimulating factor is associated with neutrophilia and eosinophilia. Hormones (Athens); 2006 Oct-Dec;5(4):303-9
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary thyroid carcinoma producing granulocyte-macrophage colony-stimulating factor is associated with neutrophilia and eosinophilia.
  • Thyroid tumors producing colony-stimulating factors associated with neutrophilia and/or eosinophilia are very rare and almost all of them concern anaplastic thyroid cancer.
  • Only one case of papillary thyroid carcinoma associated with neutrophilia and one case of medullary thyroid carcinoma associated with eosinophilia have been reported.
  • In this report a 72-year old male patient with metastatic papillary thyroid carcinoma associated with neutrophilia and eosinophilia is described.
  • While investigating the cause of neutrophilia and eosinophilia, a blind bone marrow biopsy of the posterior iliac crest was performed, which showed infiltration by papillary thyroid carcinoma.
  • As other causes of neutrophilia and eosinophilia were excluded, we assumed that these were paraneoplastic manifestations induced by GM-csF produced by the thyroid tumor. the disease progressed rapidly, despite appropriate treatment which included thyroidectomy and postoperative radioactive (131)I administration. the patient died 11 months after diagnosis because of extensive lung metastasis.
  • Neutrophilia and eosinophilia were stable findings, while serum thyroglobulin levels remained elevated throughout the follow-up period. to our knowledge, this is the first report of a patient with metastatic papillary thyroid carcinoma in whom neutrophilia and eosinophilia associated with high circulating levels of GM-csF were detected.
  • [MeSH-major] Carcinoma, Papillary / pathology. Eosinophils / pathology. Granulocyte-Macrophage Colony-Stimulating Factor / blood. Neutrophils / pathology. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17178706.001).
  • [ISSN] 1109-3099
  • [Journal-full-title] Hormones (Athens, Greece)
  • [ISO-abbreviation] Hormones (Athens)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 83869-56-1 / Granulocyte-Macrophage Colony-Stimulating Factor
  •  go-up   go-down


7. Chi HS, Wang LF, Chiang FY, Kuo WR, Lee KW: Branchial cleft cyst as the initial impression of a metastatic thyroid papillary carcinoma: two case reports. Kaohsiung J Med Sci; 2007 Dec;23(12):634-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Branchial cleft cyst as the initial impression of a metastatic thyroid papillary carcinoma: two case reports.
  • Rare branchial cleft cysts are associated with malignant tumors metastatic from the oral cavity, nasal cavity, pharynx or thyroid gland.
  • Occult thyroid papillary carcinomas often present as a solid mass in the lateral neck, with only a few cases revealing a branchial cleft cyst as the initial manifestation.
  • Herein, we report two cases of metastatic thyroid papillary carcinoma that presented as lateral neck cysts, with preoperative diagnosis of branchial cleft cyst.
  • Finally, after complete surgical resection and histopathologic examination, one case was diagnosed as cystic change of metastatic lymph node from thyroid papillary carcinoma, and the other was determined to be a branchial cleft cyst with concurrent lymph node metastasis from thyroid papillary carcinoma.
  • When a branchial cleft cyst is diagnosed by clinical or histopathologic examination, a metastatic thyroid papillary carcinoma should be considered as part of the differential diagnosis.
  • [MeSH-major] Branchioma / pathology. Carcinoma, Papillary / pathology. Carcinoma, Papillary / secondary. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18192100.001).
  • [ISSN] 1607-551X
  • [Journal-full-title] The Kaohsiung journal of medical sciences
  • [ISO-abbreviation] Kaohsiung J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


8. Melck AL, Yip L, Carty SE: The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist; 2010;15(12):1285-93
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The utility of BRAF testing in the management of papillary thyroid cancer.
  • Over the last decade, investigators have developed a clearer understanding of the genetic alterations underlying thyroid carcinogenesis.
  • A number of biomarkers involved in the pathogenesis of differentiated thyroid cancer have undergone intensive study, not only for their role in tumorigenesis, but also for their potential utility as diagnostic and prognostic indicators and therapeutic targets.
  • This review summarizes the current literature surrounding BRAF and its significance in thyroid cancer.
  • Further, we discuss how molecular analysis can be integrated into management algorithms for thyroid nodules and papillary thyroid cancer.
  • We also review what is known, to date, about the association of BRAF and papillary microcarcinoma as well as using targeted therapies for BRAF as adjuvant treatment for metastatic papillary thyroid cancer.
  • [MeSH-major] Carcinoma, Papillary / genetics. Mutation / genetics. Proto-Oncogene Proteins B-raf / genetics. Thyroid Neoplasms / genetics

  • Genetic Alliance. consumer health - Thyroid cancer, papillary.
  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endocr Pathol. 2007 Spring;18(1):1-7 [17652794.001]
  • [Cites] Endocr J. 2007 Jun;54(3):399-405 [17429154.001]
  • [Cites] Cancer. 2007 Sep 15;110(6):1218-26 [17685465.001]
  • [Cites] Endocr Pract. 2007 Sep;13(5):498-512 [17872353.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Nov;92(11):4085-90 [17785355.001]
  • [Cites] Endocr Relat Cancer. 2007 Dec;14(4):1089-97 [18045960.001]
  • [Cites] Endocr Rev. 2007 Dec;28(7):742-62 [17940185.001]
  • [Cites] Thyroid. 2007 Nov;17(11):1109-15 [17727338.001]
  • [Cites] J Surg Oncol. 2008 Mar 1;97(3):221-5 [18050283.001]
  • [Cites] J Clin Oncol. 2009 Jun 20;27(18):2977-82 [19414674.001]
  • [Cites] Thyroid. 2009 Aug;19(8):837-42 [19534623.001]
  • [Cites] Eur J Endocrinol. 2009 Sep;161(3):467-73 [19574281.001]
  • [Cites] Cancer Res. 2009 Nov 1;69(21):8317-25 [19861538.001]
  • [Cites] Thyroid. 2009 Nov;19(11):1167-214 [19860577.001]
  • [Cites] Eur J Endocrinol. 2009 Dec;161(6):923-31 [19773371.001]
  • [Cites] Radiology. 2009 Dec;253(3):854-60 [19710001.001]
  • [Cites] Surgery. 2009 Dec;146(6):1215-23 [19958951.001]
  • [Cites] Thyroid. 2009 Dec;19(12):1351-61 [19895341.001]
  • [Cites] Head Neck. 2010 Jan;32(1):38-45 [19475551.001]
  • [Cites] Cancer Cytopathol. 2010 Feb 25;118(1):17-23 [20099311.001]
  • [Cites] Thyroid. 2010 Mar;20(3):273-9 [20187782.001]
  • [Cites] J Clin Endocrinol Metab. 2010 Mar;95(3):1365-9 [20130073.001]
  • [Cites] J Clin Endocrinol Metab. 2010 Apr;95(4):1516-27 [20156922.001]
  • [Cites] Am J Clin Pathol. 2010 May;133(5):802-8 [20395530.001]
  • [Cites] Surg Oncol. 2010 Jun;19(2):e57-70 [19447608.001]
  • [Cites] J Clin Endocrinol Metab. 2010 Aug;95(8):3693-700 [20501689.001]
  • [Cites] Mod Pathol. 2008 May;21 Suppl 2:S37-43 [18437172.001]
  • [Cites] Diagn Cytopathol. 2008 Jun;36(6):425-37 [18478609.001]
  • [Cites] Endocr Relat Cancer. 2008 Jun;15(2):511-20 [18509003.001]
  • [Cites] Diagn Mol Pathol. 2008 Jun;17(2):118-25 [18382358.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Oct;93(10):3943-9 [18682506.001]
  • [Cites] J Clin Oncol. 2008 Oct 10;26(29):4714-9 [18541894.001]
  • [Cites] J Surg Oncol. 2009 Jan 1;99(1):28-31 [18942072.001]
  • [Cites] Clin Endocrinol (Oxf). 2009 Jan;70(1):139-44 [18462259.001]
  • [Cites] Ann Surg Oncol. 2009 Feb;16(2):240-5 [19034577.001]
  • [Cites] Otolaryngol Head Neck Surg. 2009 May;140(5):709-14 [19393416.001]
  • [Cites] Thyroid. 2009 May;19(5):473-7 [19348582.001]
  • [Cites] Endocr Pathol. 2009 Summer;20(2):122-6 [19370421.001]
  • [Cites] Cancer Res. 2009 Jun 1;69(11):4885-93 [19487299.001]
  • [Cites] J Clin Endocrinol Metab. 2009 Jun;94(6):2092-8 [19318445.001]
  • [Cites] Nature. 2002 Jun 27;417(6892):949-54 [12068308.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Nov;88(11):5399-404 [14602780.001]
  • [Cites] Clin Cancer Res. 2004 Apr 15;10(8):2761-5 [15102681.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Jun;89(6):2867-72 [15181070.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Oct;89(10):5175-80 [15472223.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1764-71 [15496625.001]
  • [Cites] Laryngoscope. 2004 Dec;114(12):2110-5 [15564829.001]
  • [Cites] Cytopathology. 2005 Feb;16(1):27-31 [15859312.001]
  • [Cites] Clin Cancer Res. 2006 Mar 1;12(5):1623-9 [16533790.001]
  • [Cites] Diagn Mol Pathol. 2006 Sep;15(3):136-43 [16932068.001]
  • [Cites] Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6 [17054470.001]
  • [Cites] Eur J Surg Oncol. 2006 Dec;32(10):1144-8 [16872798.001]
  • [Cites] Clin Cancer Res. 2007 Feb 15;13(4):1341-9 [17317846.001]
  • [Cites] World J Surg. 2007 May;31(5):895-904 [17347896.001]
  • [Cites] Cancer. 2007 Jul 1;110(1):38-46 [17520704.001]
  • [Cites] Ann Surg. 2007 Sep;246(3):466-70; discussion 470-1 [17717450.001]
  • (PMID = 21147872.001).
  • [ISSN] 1549-490X
  • [Journal-full-title] The oncologist
  • [ISO-abbreviation] Oncologist
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.11.1 / BRAF protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins B-raf
  • [Other-IDs] NLM/ PMC3227917
  •  go-up   go-down


9. Lee JK, Obrzut SL, Yi ES, Deftos LJ, Bouvet M: Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism. Endocr Pract; 2007 Jul-Aug;13(4):380-3
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism.
  • OBJECTIVE: To report on the management of a patient with the rare concurrence of primary hyperparathyroidism and incidentally found metastatic papillary thyroid carcinoma in an adjacent lymph node.
  • RESULTS: Primary hyperparathyroidism with concomitant occurrence of nonmedullary thyroid carcinoma is rare, occurring in less than 4% of patients.
  • We report a case of a 53-year-old woman with no prior history of endocrine disease with primary hyperparathyroidism and an incidental finding of a concurrent thyroid carcinoma.
  • In this patient, technetium 99m scintigraphy revealed a parathyroid adenoma beneath the inferior pole of the left thyroid bed.
  • The final pathology examination showed a large parathyroid adenoma with an incidental finding of a small adjacent lymph node containing metastatic papillary thyroid carcinoma.
  • The patient subsequently underwent total thyroidectomy, and the pathology evaluation revealed papillary thyroid carcinoma, follicular variant.
  • CONCLUSION: To our knowledge, this case of concomitant primary hyperparathyroidism and papillary thyroid cancer is unique in the way in which the diagnosis of metastatic papillary thyroid cancer was made.
  • The presence of parathyroid adenoma should not exclude the diagnosis of thyroid carcinoma; therefore, careful thyroid evaluation should be considered for all patients with primary hyperparathyroidism.
  • [MeSH-major] Adenoma / complications. Carcinoma, Papillary / complications. Hyperparathyroidism, Primary / complications. Parathyroid Neoplasms / complications. Thyroid Neoplasms / complications

  • Genetic Alliance. consumer health - Hyperparathyroidism, primary.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17669714.001).
  • [ISSN] 1934-2403
  • [Journal-full-title] Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • [ISO-abbreviation] Endocr Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Markou KD, Goudakos JK, Triaridis S, Televantou D, Hytiroglou P, Nikolaou A: Simultaneous metastatic papillary thyroid carcinoma and carcinoid of the small intestine in the cervical lymph node group. Thyroid; 2010 Sep;20(9):1025-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Simultaneous metastatic papillary thyroid carcinoma and carcinoid of the small intestine in the cervical lymph node group.
  • BACKGROUND: Malignancies, primary or metastatic, and infections are the main causative factors that should be included in the differential diagnosis of cervical adenopathy.
  • The histopathological examination showed that the larger mass (measuring 5 cm) was a block of lymph nodes with metastatic papillary carcinoma of the thyroid.
  • In the adjacent fibroadipose tissue, two lymph nodes with metastatic carcinoid tumor were found.
  • The smaller mass (measuring 2 cm) was a lymph node with metastatic carcinoid tumor.
  • Histopatological examination of the thyroid gland showed a lesion of papillary carcinoma, measuring 0.6 cm.
  • CONCLUSIONS: To our knowledge, this is the first report of a coexistence of metastatic papillary thyroid carcinoma and intestinal carcinoid tumor in cervical lymph nodes.
  • [MeSH-major] Carcinoid Tumor / pathology. Carcinoma, Papillary / pathology. Intestinal Neoplasms / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Iodine Radioisotopes / therapeutic use. Lymphatic Metastasis. Middle Aged. Neck / radiography. Neck / surgery. Neck Dissection. Salivary Glands / surgery. Thyroid Gland / radiography. Thyroid Gland / surgery. Thyroidectomy. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20718681.001).
  • [ISSN] 1557-9077
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes
  •  go-up   go-down


11. Kaldrymides P, Kostoglou-Athanassiou I, Gkountouvas A, Veniou E, Ziras N: Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature. Endocrine; 2010 Feb;37(1):6-10
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature.
  • Tyrosine kinase receptors have been implicated in thyroid cancer.
  • Therefore, tyrosine kinase inhibitors may be used for the treatment of advanced metastatic thyroid carcinoma.
  • The aim is to present a case of metastatic papillary thyroid carcinoma responding to the administration of sunitinib, a multi-targeted protein kinase inhibitor.
  • A patient presented with metastatic papillary thyroid carcinoma and hyperthyroidism.
  • The administration of sunitinib resulted in partial disease response in a patient with progressive metastatic papillary thyroid carcinoma.
  • Protein kinase inhibitors may prove useful in the management of advanced metastatic papillary thyroid carcinoma.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Carcinoma, Papillary / drug therapy. Carcinoma, Papillary / secondary. Indoles / therapeutic use. Pelvic Neoplasms / drug therapy. Pelvic Neoplasms / secondary. Pyrroles / therapeutic use. Thyroid Neoplasms

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thyroid. 2007 Apr;17 (4):351-5 [17465866.001]
  • [Cites] Thyroid. 2007 Nov;17 (11):1147-9 [17714037.001]
  • [Cites] Ann Intern Med. 2008 Apr 1;148(7):567 [18378960.001]
  • [Cites] CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30 [15661684.001]
  • [Cites] Br J Cancer. 2008 Aug 5;99(3):448-54 [18665181.001]
  • [Cites] Lancet Oncol. 2007 Feb;8(2):148-56 [17267329.001]
  • [Cites] Oncogene. 2003 Jul 17;22(29):4578-80 [12881714.001]
  • [Cites] JAMA. 2006 May 10;295(18):2164-7 [16684987.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Oct;91(10 ):4070-6 [16849418.001]
  • [Cites] Oncologist. 2009 Nov;14 (11):1083-7 [19887470.001]
  • [Cites] Endocrinol Metab Clin North Am. 2007 Sep;36(3):839-53, viii [17673131.001]
  • [Cites] J Clin Oncol. 2008 Oct 10;26(29):4701-4 [18541893.001]
  • [Cites] Ann Surg Oncol. 2007 Feb;14(2):942-53 [17103252.001]
  • [Cites] Oncol Res. 2004;14(4-5):175-225 [14977353.001]
  • [Cites] Ann Endocrinol (Paris). 2007 Oct;68(5):332-6 [17707761.001]
  • [Cites] Thyroid. 2006 Feb;16(2):109-42 [16420177.001]
  • [Cites] J Endocrinol. 2004 Nov;183(2):249-56 [15531713.001]
  • [Cites] J Endocrinol Invest. 1991 Jun;14(6):475-80 [1723086.001]
  • [Cites] Semin Surg Oncol. 1999 Jan-Feb;16(1):34-41 [9890738.001]
  • [Cites] J Clin Oncol. 2007 Mar 1;25(7):884-96 [17327610.001]
  • [Cites] Eur J Cancer. 2009 Jan;45(2):228-47 [19097774.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):1023-38 [19041829.001]
  • [Cites] Clin Endocrinol (Oxf). 2008 Oct;69(4):669-72 [18394019.001]
  • [Cites] Endocr Relat Cancer. 2001 Sep;8(3):161-73 [11566607.001]
  • [Cites] Eur J Cancer. 2009 Mar;45(5):765-73 [19157861.001]
  • [Cites] Prescrire Int. 2007 Aug;16(90):138-41 [17724833.001]
  • [Cites] Nat Rev Cancer. 2006 Apr;6(4):292-306 [16557281.001]
  • [Cites] J Natl Cancer Inst. 2007 Jan 3;99(1):81-3 [17202116.001]
  • [Cites] Anticancer Agents Med Chem. 2007 Nov;7(6):594-611 [18045055.001]
  • [Cites] Ann N Y Acad Sci. 2002 Jun;963:116-21 [12095936.001]
  • [Cites] J Clin Endocrinol Metab. 2009 May;94(5):1493-9 [19258410.001]
  • [Cites] Arq Bras Endocrinol Metabol. 2007 Jun;51(4):612-24 [17684624.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2006 Jan;2(1):42-52 [16932252.001]
  • [Cites] Cell. 1990 Feb 23;60(4):557-63 [2406025.001]
  • [Cites] Oncogene. 2000 Nov 20;19(49):5548-57 [11114734.001]
  • [Cites] Int J Cancer. 2000 Feb 1;85(3):384-90 [10652431.001]
  • [Cites] Cancer. 1985 Nov 1;56(9):2155-60 [3902203.001]
  • [Cites] Clin Cancer Res. 2003 Jan;9(1):327-37 [12538485.001]
  • [Cites] Anticancer Drugs. 2008 Jun;19(5):547-52 [18418222.001]
  • [Cites] Bull Cancer. 2009 Jan;96(1):95-101 [19211364.001]
  • [Cites] Hum Pathol. 2006 Jul;37(7):781-6 [16784975.001]
  • (PMID = 20963554.001).
  • [ISSN] 1559-0100
  • [Journal-full-title] Endocrine
  • [ISO-abbreviation] Endocrine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Indoles; 0 / Protein Kinase Inhibitors; 0 / Pyrroles; V99T50803M / sunitinib
  •  go-up   go-down


12. Khandelwal S, Sener SF, Purdy L, Perlman RM: I-123-guided excision of metastatic papillary thyroid cancer. J Surg Oncol; 2007 Aug 1;96(2):173-5
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] I-123-guided excision of metastatic papillary thyroid cancer.
  • The use of a gamma probe for intraoperative localization of a cervical lymph node, which contained recurrent metastatic papillary thyroid cancer, facilitated a radio-guided minimally invasive outpatient surgical procedure and resulted in complete excision of clinically occult disease.
  • [MeSH-major] Carcinoma, Papillary / surgery. Lymph Nodes / radionuclide imaging. Neck Dissection. Thyroid Neoplasms / surgery. Thyroidectomy / methods


13. Lombardi CP, Raffaelli M, Princi P, De Crea C, Bellantone R: Minimally invasive video-assisted functional lateral neck dissection for metastatic papillary thyroid carcinoma. Am J Surg; 2007 Jan;193(1):114-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minimally invasive video-assisted functional lateral neck dissection for metastatic papillary thyroid carcinoma.
  • We evaluated the feasibility of minimally invasive video-assisted functional lateral neck dissection (VALNED) in patients with papillary thyroid carcinoma (PTC).
  • [MeSH-major] Adenocarcinoma, Papillary / secondary. Adenocarcinoma, Papillary / surgery. Endoscopy / methods. Neck Dissection / methods. Thyroid Neoplasms / surgery. Video-Assisted Surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17188101.001).
  • [ISSN] 1879-1883
  • [Journal-full-title] American journal of surgery
  • [ISO-abbreviation] Am. J. Surg.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Technical Report
  • [Publication-country] United States
  •  go-up   go-down


14. Kreft A, Hansen T, Kirkpatrick CJ: Thyroid transcription factor 1 expression in cystic lesions of the neck: an immunohistochemical investigation of thyroglossal duct cysts, branchial cleft cysts and metastatic papillary thyroid cancer. Virchows Arch; 2005 Jul;447(1):9-11
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Thyroid transcription factor 1 expression in cystic lesions of the neck: an immunohistochemical investigation of thyroglossal duct cysts, branchial cleft cysts and metastatic papillary thyroid cancer.
  • Cervical metastases of papillary thyroid cancer (PTC) are of particular diagnostic importance, because they can mimic branchiogenic cysts clinically and histopathologically when undergoing cystic change.
  • Immunohistochemical stains for thyroid transcription factor 1 (TTF-1), which are positive in thyroid cancers, are reported to be valuable in establishing diagnosis.
  • [MeSH-major] Branchioma / metabolism. Carcinoma, Papillary / metabolism. Nuclear Proteins / metabolism. Thyroglossal Cyst / metabolism. Thyroid Neoplasms / metabolism. Transcription Factors / metabolism


15. Agriantonis DJ, Hall L, Wilson MA: Utility of SPECT/CT as an adjunct to planar whole body I-131 imaging: liver metastasis from papillary thyroid cancer. Clin Nucl Med; 2009 Apr;34(4):247-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Utility of SPECT/CT as an adjunct to planar whole body I-131 imaging: liver metastasis from papillary thyroid cancer.
  • We present a case of papillary thyroid cancer metastatic to the liver, a relatively rare scenario.
  • [MeSH-major] Iodine Radioisotopes / pharmacology. Liver Neoplasms / radionuclide imaging. Thyroid Neoplasms / radionuclide imaging. Tomography, Emission-Computed, Single-Photon / methods. Tomography, X-Ray Computed / methods


16. Khan OA, Roses DF, Peck V: Papillary thyroid carcinoma metastatic to skin may herald aggressive disease. Endocr Pract; 2010 May-Jun;16(3):446-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary thyroid carcinoma metastatic to skin may herald aggressive disease.
  • OBJECTIVE: To describe an unusual case of papillary thyroid carcinoma presenting as a skin lesion on the nose.
  • RESULTS: An asymptomatic 73-year-old man noted a skin lesion on his nose, which when biopsied, revealed histopathologic characteristics consistent with papillary thyroid cancer and was immunohistochemistry positive for thyroid transcription factor-1 and thyroglobulin, also consistent with a neoplasm of thyroid origin.
  • Subsequent physical examination showed a large left thyroid mass, and further workup demonstrated invasion of the trachea and surrounding musculature.
  • Fine-needle aspiration biopsy performed on the thyroid mass confirmed papillary thyroid carcinoma.
  • At operation, the cancer demonstrated fixation to the trachea and musculature, as well as infiltration of the surrounding soft tissues.
  • Only the portion of the left thyroid mass that could be mobilized was removed.
  • Final pathologic examination confirmed papillary thyroid carcinoma.
  • Cutaneous metastases of thyroid carcinoma are infrequent, and, as the presenting feature of thyroid carcinoma, are even more rare.
  • This case is noteworthy because a skin lesion was the presenting feature of thyroid carcinoma and histopathologic findings together with immunophenotyping provided the initial diagnosis.
  • This case also demonstrates that papillary thyroid carcinoma in men older than age 50 years can behave very aggressively.
  • [MeSH-major] Carcinoma, Papillary / complications. Skin Neoplasms / diagnosis. Skin Neoplasms / secondary. Thyroid Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20061298.001).
  • [ISSN] 1934-2403
  • [Journal-full-title] Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • [ISO-abbreviation] Endocr Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Yazdi S, Saadat P, Young S, Hamidi R, Vadmal MS: Acquired reactive perforating collagenosis associated with papillary thyroid carcinoma: a paraneoplastic phenomenon? Clin Exp Dermatol; 2010 Mar;35(2):152-5
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acquired reactive perforating collagenosis associated with papillary thyroid carcinoma: a paraneoplastic phenomenon?
  • Four months later, metastatic papillary thyroid cancer was diagnosed.
  • [MeSH-major] Carcinoma, Papillary / complications. Collagen Diseases / etiology. Diabetes Mellitus, Type 1 / complications. Paraneoplastic Syndromes / etiology. Thyroid Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Diabetes Type 1.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19438550.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


18. Dokuzlar U, Erişen L, Kasapoğlu F, Coşkun H, Basut O, Onart S, Hizalan I: Unexpected findings in the neck dissection specimens for primary head and neck squamous cell carcinoma. Kulak Burun Bogaz Ihtis Derg; 2009 Jan-Feb;19(1):9-15
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unexpected findings in the neck dissection specimens for primary head and neck squamous cell carcinoma.
  • OBJECTIVES: We aimed to determine the incidence of unexpected pathological findings observed during the histopathological examination of the neck dissection specimens performed for primary head and neck squamous cell carcinoma, and their impacts on the treatment and follow-up plans.
  • PATIENTS AND METHODS: We retrospectively reviewed 410 patients (369 males, 41 females; 169 patients unilateral, 241 patients bilateral) with a diagnosis of squamous cell carcinoma of head and neck, who underwent 651 neck dissections.
  • These unexpected findings were tuberculosis in eight patients (2%), metastatic papillary thyroid carcinoma in three patients (0.7%), Warthin,s tumor in one patient and cystic hygroma in one patient.
  • All patients who had metastatic papillary thyroid carcinoma received radioactive iodine treatment after thyroidectomy.
  • In control examinations, none of these cases had problem related to neither primary disease nor thyroid pathology.
  • Most frequently seen unexpected findings were tuberculosis lymphadenitis and metastatic papillary thyroid carcinoma.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Head and Neck Neoplasms / pathology. Lymph Nodes / pathology. Neck Dissection
  • [MeSH-minor] Carcinoma, Papillary / secondary. Female. Humans. Laryngeal Neoplasms / pathology. Laryngeal Neoplasms / surgery. Laryngectomy. Lymphatic Metastasis. Male. Retrospective Studies. Thyroid Neoplasms / secondary. Tuberculosis, Lymph Node / complications. Tuberculosis, Lymph Node / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19793041.001).
  • [ISSN] 1300-7475
  • [Journal-full-title] Kulak burun boğaz ihtisas dergisi : KBB = Journal of ear, nose, and throat
  • [ISO-abbreviation] Kulak Burun Bogaz Ihtis Derg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


19. Nishijima H, Kitahara N, Murata M, Egami N: [A case of papillary thyroid carcinoma metastatic to the sphenoid sinus presenting with epistaxis]. Nihon Jibiinkoka Gakkai Kaiho; 2010 Feb;113(2):62-6
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of papillary thyroid carcinoma metastatic to the sphenoid sinus presenting with epistaxis].
  • Distant metastasis from differentiated thyroid carcinoma is rare and metastasis to the paranasal sinus is extremely rare.
  • We report a case of differentiated papillary thyroid carcinoma (PTC) with metastases to the sphenoid sinus presenting with epistaxis.
  • Histopathological diagnosis using endoscopic biopsy indicated a metastatic PTC tumor.
  • Compared to the primary site, the metastatic tumor was poorly differentiated thyroid carcinoma.
  • [MeSH-major] Carcinoma, Papillary / pathology. Paranasal Sinus Neoplasms / secondary. Sphenoid Sinus. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20225705.001).
  • [ISSN] 0030-6622
  • [Journal-full-title] Nihon Jibiinkoka Gakkai kaiho
  • [ISO-abbreviation] Nippon Jibiinkoka Gakkai Kaiho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


20. Diaz J, Chawla M, Simoff M: Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in the Diagnosis of Metastatic Thyroid Cancer. J Bronchology Interv Pulmonol; 2009 Jan;16(1):70-1
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in the Diagnosis of Metastatic Thyroid Cancer.
  • Since its first application in 1992, endobronchial ultrasound, in conjunction with transbronchial needle aspiration, has proven to be an efficient tool for lung cancer staging.
  • Its use in the diagnosis of solitary intrapulmonary tumors and preoperative assessment of tracheobronchial invasion from thyroid cancer has also been reported.
  • We present a case of metastatic papillary thyroid cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration in a patient with a paratracheal mass.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23168478.001).
  • [ISSN] 1944-6586
  • [Journal-full-title] Journal of bronchology & interventional pulmonology
  • [ISO-abbreviation] J Bronchology Interv Pulmonol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Hwang I, Lee SK, Cho KJ, Kim KR: Heterotopic intrathymic thyroid tissue. Pathol Int; 2006 Oct;56(10):629-32
MedlinePlus Health Information. consumer health - Lymphatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Heterotopic intrathymic thyroid tissue.
  • Heterotopic intrathymic thyroid tissue is an extremely rare condition, but it is important to distinguish it from metastases of clinically undetected thyroid carcinoma because metastatic papillary thyroid carcinoma is often so well differentiated, simulating normal thyroid tissue.
  • Described herein are histological findings of heterotopic intrathymic thyroid tissue that was incidentally identified in a woman with papillary thyroid carcinoma during histological examination of a radical neck dissection specimen.
  • These findings emphasize that this rare incidence may occur and should be differentiated from metastatic papillary carcinoma.
  • Histologically, the patient's intrathymic thyroid follicles were identical to the normal thyroid follicles, having flat cuboidal cells with uniformly small nuclei without nuclear grooves or inclusions.
  • The follicular cells had a low Ki-67 labeling index close to zero, and immunonegativity for galectin-3, HBME-1, and RET oncoprotein, in contrast to the tumor cells in primary papillary thyroid carcinoma of the patient.
  • To the authors' knowledge this is the first case report of intrathymic heterotopic thyroid tissue posing a diagnostic difficulty in a patient with papillary thyroid carcinoma.
  • [MeSH-major] Choristoma / pathology. Lymphatic Diseases / pathology. Thymus Gland / pathology. Thyroid Gland
  • [MeSH-minor] Biomarkers, Tumor / genetics. Biomarkers, Tumor / metabolism. Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / genetics. Carcinoma, Papillary / metabolism. Carcinoma, Papillary / pathology. Diagnosis, Differential. Female. Galectin 3 / genetics. Galectin 3 / metabolism. Gene Expression Regulation, Neoplastic. Humans. Ki-67 Antigen / genetics. Ki-67 Antigen / metabolism. Middle Aged. Proto-Oncogene Proteins c-ret / genetics. Proto-Oncogene Proteins c-ret / metabolism. Thyroid Neoplasms / diagnosis. Thyroid Neoplasms / genetics. Thyroid Neoplasms / metabolism. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16984621.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Galectin 3; 0 / HBME-1 antigen; 0 / Ki-67 Antigen; EC 2.7.10.1 / Proto-Oncogene Proteins c-ret; EC 2.7.10.1 / RET protein, human
  •  go-up   go-down


22. Khafif A, Ben-Yosef R, Abergel A, Kesler A, Landsberg R, Fliss DM: Elective paratracheal neck dissection for lateral metastases from papillary carcinoma of the thyroid: is it indicated? Head Neck; 2008 Mar;30(3):306-10
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Elective paratracheal neck dissection for lateral metastases from papillary carcinoma of the thyroid: is it indicated?
  • BACKGROUND: Therapeutic paratracheal neck dissection for patients with papillary carcinoma of the thyroid is standard treatment.
  • METHODS: Thirty-seven patients with papillary carcinoma of the thyroid and evidence of positive adenopathy at levels II-V underwent selective neck dissection and elective/therapeutic paratracheal neck dissection.
  • All specimens showed metastases from papillary thyroid carcinoma: 100% (37/37) in the jugular chain of lymphatics and 83.7% (31/37) in the paratracheal region.
  • CONCLUSION: The high rate of occult metastases in the paratracheal region and the low rate of surgical morbidity speak in favor of elective paratracheal neck dissection in patients with metastatic papillary carcinoma of the thyroid.
  • [MeSH-major] Carcinoma, Papillary / surgery. Neck Dissection / methods. Thyroid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley Periodicals, Inc. Head Neck 2008.
  • (PMID = 17615566.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Pietarinen-Runtti P, Apajalahti S, Robinson S, Passador-Santos F, Leivo I, Mäkitie AA: Cystic neck lesions: clinical, radiological and differential diagnostic considerations. Acta Otolaryngol; 2010 Feb;130(2):300-4
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: Metastatic disease should always be considered as a potential differential diagnosis in the adult patient with a cystic neck lesion.
  • In older patients metastatic lymph nodes may be easily misdiagnosed as BCC.
  • This study aimed to investigate the incidence of unsuspected carcinoma in routinely excised cervical cysts at a tertiary care teaching hospital and to determine the characteristics of benign BCC and cystic malignancy in preoperative imaging.
  • RESULTS: Metastatic squamous cell carcinoma was demonstrated histologically postoperatively in six (3.1%) patients and metastatic papillary thyroid carcinoma in one (0.5%) patient.
  • Therefore, the incidence of unsuspected carcinoma in the cystic neck lesions initially diagnosed as BCC was 3.6%.
  • [MeSH-major] Branchioma / pathology. Carcinoma, Papillary / pathology. Carcinoma, Squamous Cell / secondary. Lymphatic Metastasis / pathology. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19593684.001).
  • [ISSN] 1651-2251
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


24. Chen L, Brainard JA: Pancreatic metastasis from papillary thyroid carcinoma diagnosed by endoscopic ultrasound-guided fine needle aspiration: a case report. Acta Cytol; 2010 Jul-Aug;54(4):640-4
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic metastasis from papillary thyroid carcinoma diagnosed by endoscopic ultrasound-guided fine needle aspiration: a case report.
  • BACKGROUND: The incidence of papillary thyroid carcinoma that has metastasized to the pancreas is extremely rare.
  • CASE: A case of pancreatic metastatic papillary thyroid carcinoma occurred in an 82-year-old man with a prior history of thyroid papillary carcinoma, resected 5 years earlier.
  • The microscopic examination showed a highly cellular smear composed of conspicuous papillary architecture at low magnification.
  • Nuclear changes characteristic of papillary thyroid carcinoma were identified.
  • CONCLUSION: EUS-guided fine needle aspiration cytology can be a reliable method for the diagnosis of metastatic papillary thyroid carcinoma of the pancreas.
  • [MeSH-major] Adenocarcinoma, Papillary / secondary. Pancreatic Neoplasms / secondary. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20715671.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 9010-34-8 / Thyroglobulin
  •  go-up   go-down


25. Feng D, Rhatigan R, Shuja S, Wolfson D, Makary R, Koch K, Masood S: Papillary thyroid carcinoma with metastasis to the frontal skull. Diagn Cytopathol; 2009 Jul;37(7):522-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary thyroid carcinoma with metastasis to the frontal skull.
  • Papillary thyroid carcinoma with metastasis to the frontal skull is extremely rare.
  • We report a case of unsuspected papillary thyroid carcinoma with frontal skull metastasis.
  • The diagnosis was a metastatic carcinoma.
  • Surgical biopsy demonstrated histological and cytological features of papillary thyroid carcinoma including prominent papillae, nuclear overlapping, grooves, and intranuclear pseudoinclusions.
  • Thus, a diagnosis of metastatic papillary thyroid carcinoma was rendered.
  • Though skull metastasis of thyroid carcinoma is rare, it should be considered in the differential diagnosis when a skull mass lesion is encountered.
  • [MeSH-major] Skull Neoplasms / pathology. Skull Neoplasms / secondary. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 Wiley-Liss, Inc.
  • (PMID = 19459156.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


26. Roh JL, Yoon YH, Park CI: Chyle leakage in patients undergoing thyroidectomy plus central neck dissection for differentiated papillary thyroid carcinoma. Ann Surg Oncol; 2008 Sep;15(9):2576-80
Hazardous Substances Data Bank. CHOLESTEROL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chyle leakage in patients undergoing thyroidectomy plus central neck dissection for differentiated papillary thyroid carcinoma.
  • BACKGROUND: Chyle leakage is an uncommon complication of lateral neck dissection for metastatic papillary thyroid carcinoma (PTC).
  • [MeSH-major] Carcinoma, Papillary / surgery. Chyle. Postoperative Complications. Thyroid Neoplasms / surgery. Thyroidectomy / adverse effects

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18592317.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Triglycerides; 97C5T2UQ7J / Cholesterol
  •  go-up   go-down


27. Griniatsos J, Tsigris C, Kanakis M, Kaltsas G, Michail O, Dimitriou N, Argyrakopoulou G, Delladetsima I, Kyriakou V, Syriou V, Alexandraki K, Pikoulis E, Giannopoulos A, Kouraklis G, Diamanti-Kandaraki E, Felekouras E: Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006. Anticancer Res; 2009 Dec;29(12):5163-9
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.
  • OBJECTIVE: To examine existing evidence, trends and possible factors that may have affected the incidence of papillary thyroid cancer (PTC) among patients undergoing thyroidectomies in an iodine-sufficient population of Greece.
  • STUDY DESIGN: All histology records from the patients who had undergone thyroid surgery at the Department of Surgery Laiko Hospital, Athens, Greece from January 1991 to December 2006 were retrospectively analyzed.
  • Thyroid tumors were classified according to the WHO classification system and were staged according to the TNM staging system.
  • From 1999 onwards, thyroid surgery shifted towards total thyroidectomy, while statistically significantly increased incidence of PTC and papillary microcarcinoma detection and decreased incidence of PTC greater than 10 mm detection in the whole population were noticed.
  • Moreover, from 1999 onwards, smaller size of primary tumors, higher incidence of T1 tumors, lower incidence of T4 tumors, lower incidence of metastatically infiltrated peritracheal lymph nodes, higher incidence of stage I tumors and lower incidence of stage IV tumors were documented.
  • CONCLUSION: The increased incidence of PTC clearly correlated to the increased incidence of papillary microcarcinoma detection, reflecting the proportion for total thyroidectomy as well as changes in the diagnostic approach boosted by more careful pathological examination, rather than the effect of environmental factors such as the Chernobyl accident.
  • [MeSH-major] Adenocarcinoma, Follicular / epidemiology. Adenoma, Oxyphilic / epidemiology. Carcinoma / epidemiology. Carcinoma, Medullary / epidemiology. Carcinoma, Papillary / epidemiology. Thyroid Neoplasms / epidemiology. Thyroidectomy

  • Genetic Alliance. consumer health - Thyroid cancer, papillary.
  • Genetic Alliance. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20044632.001).
  • [ISSN] 1791-7530
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


28. Ralli M, Cohan P, Lee K: Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer. J Endocrinol Invest; 2005 Mar;28(3):270-3
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer.
  • Recombinant human TSH (rhTSH) is increasingly employed in stimulating radioiodine (131I) uptake in adults with well-differentiated thyroid cancer (WDTC) for diagnostic scanning, and preliminary evidence suggests that it may have a role in radioactive iodine therapy as well.
  • We report a case of a 13-yr-old boy presenting with metastatic papillary thyroid cancer.
  • A diagnostic whole body scan (WBS) demonstrated multiple foci of uptake in the neck, thyroid bed and chest.
  • His serum TSH only increased to 14.2 microU/ml (0.3-4.7) upon thyroid hormone withdrawal.
  • This case highlights the safety and effectiveness of rhTSH stimulated radioablation in pediatric WDTC, and proposes to invite controlled studies to further investigate pediatric rhTSH use, particularly in patients in whom thyroid hormone withdrawal is not a viable option.
  • [MeSH-major] Carcinoma, Papillary / drug therapy. Thyroid Neoplasms / drug therapy. Thyrotropin / therapeutic use
  • [MeSH-minor] Adolescent. Combined Modality Therapy. Humans. Male. Recombinant Proteins / therapeutic use. Thyroglobulin / blood. Thyroid Function Tests. Thyroidectomy. Whole-Body Irradiation

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Endocrinol Invest. 2002 Jan;25(1):18-24 [11883862.001]
  • [Cites] J Nucl Med. 1986 Oct;27(10):1519-27 [3760975.001]
  • [Cites] Eur J Endocrinol. 2001 Jan;144(1):5-11 [11174831.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Mar;88(3):1319-22 [12629125.001]
  • [Cites] J Endocrinol Invest. 1999;22(11 Suppl):30-4 [10727003.001]
  • [Cites] N Engl J Med. 1997 Sep 25;337(13):888-96 [9302303.001]
  • [Cites] Endocr Pract. 2000 Nov-Dec;6(6):460-4 [11155220.001]
  • [Cites] N Engl J Med. 1998 Jan 29;338(5):297-306 [9445411.001]
  • [Cites] Br J Cancer. 1995 Sep;72(3):777-83 [7669594.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Nov;86(11):5148-51 [11701668.001]
  • [Cites] Thyroid. 2001 Sep;11(9):865-9 [11575856.001]
  • [Cites] J Nucl Med. 2001 Jun;42(6):975-83 [11390565.001]
  • [Cites] J Clin Endocrinol Metab. 1994 Jan;78(1):188-96 [8288703.001]
  • [Cites] J Nucl Med. 1998 Jul;39(7):1202-7 [9669394.001]
  • [Cites] Thyroid. 2000 Sep;10(9):767-78 [11041454.001]
  • [Cites] N Engl J Med. 1982 May 13;306(19):1136-40 [6280047.001]
  • [Cites] Thyroid. 2002 Aug;12(8):683-702 [12225637.001]
  • [Cites] Br J Radiol. 1986 Jan;59(697):45-51 [3947807.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Nov;84(11):3877-85 [10566623.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Sep;87(9):4063-8 [12213846.001]
  • [Cites] Haematologica. 1998 Aug;83(8):767-8 [9793274.001]
  • [Cites] Thyroid. 2001 Nov;11(11):1025-30 [11762711.001]
  • (PMID = 15952413.001).
  • [ISSN] 0391-4097
  • [Journal-full-title] Journal of endocrinological investigation
  • [ISO-abbreviation] J. Endocrinol. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Recombinant Proteins; 9002-71-5 / Thyrotropin; 9010-34-8 / Thyroglobulin
  •  go-up   go-down


29. Al-Saif O, Farrar WB, Bloomston M, Porter K, Ringel MD, Kloos RT: Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab; 2010 May;95(5):2187-94
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.
  • OBJECTIVE: The objective of the study was to determine the outcome of surgical resection of metastatic papillary thyroid cancer (PTC) in cervical lymph nodes after failure of initial surgery and I(131) therapy.
  • SETTING: The study was conducted at a university-based tertiary cancer hospital.
  • [MeSH-major] Carcinoma, Papillary / surgery. Lymph Node Excision / statistics & numerical data. Lymph Nodes / surgery. Thyroid Neoplasms / surgery

  • Genetic Alliance. consumer health - Thyroid cancer, papillary.
  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Clin Endocrinol Metab. 2010 May;95(5):2061-3 [20444934.001]
  • [Cites] Laryngoscope. 2008 May;118(5):768-75 [18197134.001]
  • [Cites] Arch Surg. 2006 May;141(5):489-94; discussion 494-6 [16702521.001]
  • [Cites] Surg Oncol Clin N Am. 1996 Jan;5(1):43-63 [8789493.001]
  • [Cites] Curr Probl Surg. 1994 Dec;31(12):933-1012 [7956323.001]
  • [Cites] Head Neck. 2009 Sep;31(9):1152-63 [19360746.001]
  • [Cites] J Clin Oncol. 2009 Apr 1;27(10):1675-84 [19255327.001]
  • [Cites] J Endocrinol Invest. 2002 Jun;25(6):526-31 [12109624.001]
  • [Cites] N Engl J Med. 1998 Jan 29;338(5):297-306 [9445411.001]
  • [Cites] Thyroid. 2009 Nov;19(11):1167-214 [19860577.001]
  • [Cites] World J Surg. 2004 Nov;28(11):1110-4 [15490054.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Sep;90(9):5047-57 [15972576.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Apr;86(4):1447-63 [11297567.001]
  • [Cites] Cancer. 1998 Dec 15;83(12):2638-48 [9874472.001]
  • [Cites] Wien Klin Wochenschr. 1988 May 27;100(11):342-6 [3407192.001]
  • [Cites] Thyroid. 2006 Feb;16(2):109-42 [16420177.001]
  • [Cites] Eur J Surg Suppl. 2003 Jul;(588):14-7 [15200037.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2004 Oct;130(10):1214-6 [15492172.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1991 Jun;117(6):601-5 [2036180.001]
  • [Cites] Medicine (Baltimore). 1977 May;56(3):171-96 [859443.001]
  • [Cites] J Natl Compr Canc Netw. 2007 Jul;5(6):568-621 [17623612.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Apr;87(4):1490-8 [11932270.001]
  • [Cites] Curr Treat Options Oncol. 2005 Jul;6(4):323-38 [15967085.001]
  • (PMID = 20332244.001).
  • [ISSN] 1945-7197
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA124570
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ: Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid; 2010 Feb;20(2):147-52
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
  • BACKGROUND: Recurrence of regional cervical lymph nodes in patients with papillary thyroid carcinoma (PTC) is not uncommon, and is an important factor affecting the quality of life.
  • RESULTS: Tumor size >2 cm, presence of extrathyroid tumor spread, high T stage, and presence of lymph node metastasis were associated with regional lymph node recurrence in univariate analysis (p < 0.05).
  • Among them, only the N stage was significantly associated with regional recurrence in multivariate analysis (p < 0.05).
  • Among 130 patients without lymph node metastasis, regional recurrence occurred in 13 patients (10%), and the frequent levels of regional recurrence were levels II-IV of ipsilateral neck.
  • In the patients with lymph node metastasis, the frequent levels were levels IV-VI of ipsilateral side and level II of the contralateral side.
  • However, if any risk factors for regional recurrence, including large tumor size, presence of extrathyroid spread, high T stage, and presence of lymph node metastasis, are detected by preoperative and intraoperative evaluation, a systematic compartment-oriented lymphadenectomy should be considered because of the high possibility of regional recurrence.
  • [MeSH-major] Carcinoma, Papillary / pathology. Neoplasm Recurrence, Local / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Papillary / pathology. Adenocarcinoma, Papillary / surgery. Adolescent. Adult. Aged. Aged, 80 and over. Child. Combined Modality Therapy. Disease-Free Survival. Female. Humans. Lymph Nodes / pathology. Lymphatic Metastasis / pathology. Male. Middle Aged. Neck Dissection. Prognosis. Retrospective Studies. Risk Factors. Thyroidectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19785522.001).
  • [ISSN] 1557-9077
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


31. Kennedy TL, Riefkohl WL: Lingual thyroid carcinoma with nodal metastasis. Laryngoscope; 2007 Nov;117(11):1969-73
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lingual thyroid carcinoma with nodal metastasis.
  • OBJECTIVES: To discuss treatment options and surgical management of lingual thyroid carcinoma with cervical metastasis.
  • STUDY DESIGN: Lingual thyroid is relatively uncommon, and carcinoma of the lingual thyroid is extremely rare, with only 40 cases reported.
  • We report a new case of a young female who presented with a cervical neck mass found to represent metastatic papillary thyroid carcinoma.
  • Further workup revealed the patient's only thyroid tissue was located at the tongue base and was the site of the primary tumor.
  • Management of lingual thyroid carcinoma and review of the literature is discussed.
  • METHODS: A case report and review of the literature of lingual thyroid carcinoma.
  • RESULTS: A young female presented with a left neck mass diagnosed as metastatic papillary thyroid carcinoma.
  • Review of the computed tomography scan of the neck revealed a tongue base mass, absence of an othotopic thyroid gland and bilateral cervical lymphandenopathy.
  • Bilateral selective neck dissections with removal of the tongue base lesion confirmed the diagnosis of lingual thyroid carcinoma with multiple left cervical nodal metastases.
  • CONCLUSIONS: A case of lingual papillary thyroid carcinoma with cervical metastasis is reported.
  • Treatment is best managed with surgical excision of all thyroid tissue followed by radioactive iodine ablation.
  • Surgical approaches to the tongue base need to be considered based on the size of the lingual primary tumor and the need to address lymph node metastases gland.
  • This is the first reported case in the literature of lingual papillary thyroid carcinoma presenting with cervical nodal metastasis in a female with absence of an orthotopic thyroid gland.
  • This is also the first report to show that papillary and not follicular cell carcinoma is the predominating histopathology in lingual thyroid carcinoma.
  • [MeSH-major] Carcinoma, Papillary / surgery. Lymph Nodes / pathology. Thyroid Neoplasms / surgery. Tongue Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17828053.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  •  go-up   go-down


32. Chen MY, Jung SM, Ng KK, Chang TC: Pulmonary papillary serous adenocarcinoma with intraperitoneal and ovarian tumors: identification of primary site. A case report. Int J Gynecol Cancer; 2006 Jan-Feb;16 Suppl 1:231-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary papillary serous adenocarcinoma with intraperitoneal and ovarian tumors: identification of primary site. A case report.
  • Papillary serous adenocarcinoma has been recognized as a highly malignant ovarian cancer and is also not uncommonly seen in primary lung cancer.
  • We present a patient who was initially diagnosed and treated as stage IV papillary serous ovarian cancer with diffuse pulmonary metastases.
  • Only transient symptomatic improvement was achieved after standard chemotherapy for ovarian cancer, and then she died of respiratory distress during treatment.
  • Poor tumor response to chemotherapy prompted us to reevaluate the previous bronchoscopic biopsy, and immunohistochemical studies, which were cytokeratin (CK) 7 positive, CK20 negative, and thyroid transcription factor-1 (TTF-1)-positive, provided irrefutable evidences for the diagnosis of primary lung cancer.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Lung Neoplasms / pathology. Ovarian Neoplasms / pathology. Peritoneal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16515596.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / KRT20 protein, human; 0 / KRT7 protein, human; 0 / Keratin-20; 0 / Keratin-7; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / thyroid nuclear factor 1; 68238-35-7 / Keratins; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


33. Jacobson AS, Wenig BM, Urken ML: Collision tumor of the thyroid and larynx: a patient with papillary thyroid carcinoma colliding with laryngeal squamous cell carcinoma. Thyroid; 2008 Dec;18(12):1325-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collision tumor of the thyroid and larynx: a patient with papillary thyroid carcinoma colliding with laryngeal squamous cell carcinoma.
  • Collision tumors involving the thyroid gland and/or neck region are especially uncommon, with most reported cases involving papillary thyroid carcinoma in coexistence with medullary thyroid carcinoma, follicular carcinoma, and metastatic disease, the latter including a rare occurrence of metastatic liposarcoma and thyroid papillary carcinoma.
  • A collision tumor of papillary thyroid carcinoma and squamous cell carcinoma primary to the thyroid has also been reported.
  • SUMMARY: We now report a collision tumor comprised of well-differentiated papillary thyroid carcinoma and squamous cell carcinoma that originated as a laryngeal primary tumor.
  • Histologically, the thyroid mass is consisted of well-differentiated papillary thyroid carcinoma.
  • The laryngeal mass consisted of in situ and invasive squamous cell carcinoma.
  • Additionally, cervical lymph nodes showed metastatic carcinoma, including independent cervical lymph nodes with metastatic squamous cell carcinoma only, cervical lymph nodes with metastatic papillary thyroid carcinoma only, and cervical lymph nodes with foci of both papillary thyroid carcinoma and squamous cell carcinoma.
  • CONCLUSION: As best we can determine this is the first publication of a collision tumor comprised of a well-differentiated papillary thyroid carcinoma and squamous cell carcinoma that originated as a laryngeal primary tumor.
  • For any patient with a thyroid mass that appears to be in continuity with a laryngeal mass, more commonly one would find invasive thyroid cancer, but one must consider a collision tumor in the differential diagnosis.
  • [MeSH-major] Carcinoma, Papillary / pathology. Carcinoma, Squamous Cell / pathology. Laryngeal Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Aged. Humans. Larynx / pathology. Lymphatic Metastasis / pathology. Male. Thyroid Gland / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19067640.001).
  • [ISSN] 1557-9077
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Simpson KW, Albores-Saavedra J: Unusual findings in papillary thyroid microcarcinoma suggesting partial regression: a study of two cases. Ann Diagn Pathol; 2007 Apr;11(2):97-102
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual findings in papillary thyroid microcarcinoma suggesting partial regression: a study of two cases.
  • Histologic changes of regression have been recognized in many malignant tumors, although they have not been documented in thyroid carcinoma.
  • We analyze here the histologic features of 2 cases of papillary thyroid microcarcinoma, one of the diffuse sclerosing variant and another multicentric of the follicular variant, that suggest partial regression.
  • The histologic and clinical features of the 2 thyroid microcarcinomas were compared with the features of regression reported in other tumors.
  • In addition, immunoperoxidase stains for thyroglobulin and thyroid transcription factor-1 were performed on the metastatic and primary lesions of each case.
  • Immunostains for CD4 and CD8 performed on the thyroid lesions were also examined.
  • Both patients presented with metastatic papillary thyroid carcinoma in regional lymph nodes with no clinical or radiologic evidence of primary tumor in the thyroid glands.
  • When examined, the thyroid glands revealed only microscopic foci of papillary thyroid carcinoma measuring less than 1.5 mm, diffuse sclerosis and a lymphocytic infiltrate mainly composed of cytotoxic T lymphocytes around the neoplastic microfollicles.
  • Numerous psammoma bodies were also found in the thyroid of case 1, and venulitis similar to that seen in acute hepatic rejection was also seen in the microcarcinoma of case 2.
  • The 2 patients reported had papillary thyroid microcarcinomas measuring less than 1.5 mm and features suggestive of regression characterized by extensive fibrosis, an accompanying T lymphocyte infiltrate, venulitis, and only a few clusters of neoplastic cells or a few neoplastic follicles.
  • Thus, we believe that these histologic changes suggest regression because papillary thyroid microcarcinomas measuring less than 1.5 mm do not metastasize and have been considered innocuous or medical curiosities.
  • [MeSH-major] Carcinoma, Papillary / secondary. Neoplasm Regression, Spontaneous / pathology. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17349567.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / thyroid nuclear factor 1; 9010-34-8 / Thyroglobulin
  •  go-up   go-down


35. Lang B, Lo CY, Chan WF, Lam KY, Wan KY: Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability. Ann Surg Oncol; 2007 May;14(5):1551-9
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
  • BACKGROUND: The AJCC/UICC TNM staging system (TNM) is a widely accepted system for differentiated thyroid carcinoma (DTC).
  • The objective of the present study was to evaluate the potential changes in cancer-specific survival (CSS) after reclassification from fifth to sixth edition TNM.
  • RESULTS: Upon reclassification, the proportion of T1 and T3 tumors increased from 14.2 to 33.4% and 10.0 to 33.7%; T2 and T4 decreased from 44.2 to 25.0% and 31.6 to 7.9%, respectively; N0 remained unchanged at 66.0%; N1a decreased from 25.7 to 4.7%; N1b increased from 8.4 to 29.3%; stages I and IV tumors increased from 55.7 to 60.3% and 3.4 to 17.6%, respectively; stages II and III tumors decreased from 20.5 to 13.9% and 20.4 to 8.2%, respectively.
  • Significant differences in CSS were observed between stage III (fifth edition) and stage III (sixth edition) and between stage IV (fifth edition) and stage IVA (sixth edition).
  • [MeSH-major] Thyroid Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / secondary. Adenocarcinoma / therapy. Adenocarcinoma, Follicular / pathology. Adenocarcinoma, Follicular / secondary. Adenocarcinoma, Follicular / therapy. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Papillary / pathology. Carcinoma, Papillary / secondary. Carcinoma, Papillary / therapy. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / secondary. Carcinoma, Squamous Cell / therapy. Cell Differentiation. Child. Cohort Studies. Female. Follow-Up Studies. Humans. Lymphatic Metastasis / pathology. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Staging. Prognosis. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ann Surg Oncol. 2007 May;14(5):1521-2 [17294077.001]
  • (PMID = 17318278.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Freschi G, Landi L, Castagnoli A, Taddei A, Bechi P, Bucciarelli G: Advanced thyroid carcinoma: an experience of 385 cases. Eur J Surg Oncol; 2006 Jun;32(5):577-82
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Advanced thyroid carcinoma: an experience of 385 cases.
  • AIMS: To report clinical outcomes of a large series of cases with advanced thyroid cancer.
  • STUDY DESIGN: Three hundred and eighty-five patients at the UICC stages III and IV were selected for the study with thyroid cancer.
  • RESULTS: Papillary carcinoma and sclerosing carcinoma have better survival than the Hürthle cell and insular types.
  • CONCLUSIONS: Surgical treatment is the primary treatment of thyroid carcinoma.
  • The combined treatments of surgery, metabolic beam therapy, suppressive hormone therapy, radiotherapy and chemotherapy cure a high percentage of patients with the tumour at an advanced stage.
  • [MeSH-major] Carcinoma / surgery. Thyroid Neoplasms / surgery. Thyroidectomy
  • [MeSH-minor] Adenocarcinoma / surgery. Adolescent. Adult. Aged. Aged, 80 and over. Antineoplastic Agents, Hormonal / therapeutic use. Carcinoma, Papillary / surgery. Chemotherapy, Adjuvant. Female. Follow-Up Studies. Humans. Lymphatic Metastasis / pathology. Male. Middle Aged. Neoadjuvant Therapy. Neoplasm Recurrence, Local / surgery. Neoplasm Staging. Radiotherapy, Adjuvant. Risk Assessment. Survival Rate. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16644177.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal
  •  go-up   go-down


37. Spriano G, Ruscito P, Pellini R, Appetecchia M, Roselli R: Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital; 2009 Dec;29(6):312-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma.
  • The meaning of nodal metastases in well-differentiated thyroid carcinoma is controversial.
  • The Authors analyse the impact of lymphatic spread reviewing 1503 cases of well-differentiated thyroid carcinoma treated at the National Cancer Institute of Rome between 1988 and 2005, in order to detect significant prognostic factors through multivariate analysis.
  • Overall, 462 cases of locally advanced well-differentiated thyroid carcinoma, were considered.
  • A multivariate analysis of a subgroup, comprising 97 N+ consecutive cases of well-differentiated thyroid carcinoma, previously untreated, was performed to study prognostic factors for local (N+) and distant (M+) metastasis in well-differentiated thyroid carcinoma.
  • Of the 97 cases, 88 were submitted to surgery for a large well-differentiated thyroid carcinoma, 9 for occult differentiated thyroid carcinoma.
  • After surgery, 12 patients were lost to follow-up, 8 resulted pathologically negative, therefore only 77 cases of pN1 well-differentiated thyroid carcinoma were studied.
  • Considering all cases of well-differentiated thyroid carcinoma, 10-year-overall survival was 58.7% for locally advanced well-differentiated thyroid carcinoma, compared to 94.8% in low stage cases.
  • The Authors present a retrospective study of 77 patients with primary differentiated thyroid carcinoma, submitted to thyroidectomy and neck dissection aimed at analysing distribution of nodal metastases according to Robbins' levels classification and defining their prognostic value.
  • All N1b cases, retrospectively reviewed (n. 77), presented clinical and histological evidence of neck nodes metastases from differentiated thyroid carcinoma; histological reports indicated tumour localisation and topographical distribution of metastases; papillary carcinoma was the most common type (72 cases), followed by follicular carcinoma (5 cases).
  • Cervical level IV was the most frequently involved (52%), extra-capsular spread of metastases was identified in 22% of the cases.
  • Statistically significant prognostic factors for distant metastases and recurrence on the neck were follicular carcinoma (p < 0.01) and extra-capsular spread (p < 0.001).
  • In the Authors' experience, histological grade of differentiation, wide tumour excision and neck dissection, in cases of N1b well-differentiated thyroid carcinoma, without residual disease (R1, R2), in the central and lateral neck, are determinant prognostic factors.
  • [MeSH-major] Carcinoma, Papillary / secondary. Thyroid Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Follicular. Adolescent. Adult. Aged. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Prognosis. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 1992 May;102(5):486-91 [1573942.001]
  • [Cites] Surgery. 2006 Dec;140(6):1050-4; discussion 1054-5 [17188156.001]
  • [Cites] J Exp Clin Cancer Res. 1997 Sep;16(3):333-5 [9387910.001]
  • [Cites] Br J Surg. 1998 Feb;85(2):252-4 [9501829.001]
  • [Cites] Otolaryngol Clin North Am. 1998 Oct;31(5):823-31 [9735110.001]
  • [Cites] World J Surg. 1999 Sep;23(9):970-3; discussion 973-4 [10449830.001]
  • [Cites] Cancer. 1975 Sep;36(3):1138-46 [1182668.001]
  • [Cites] Ann Surg. 1976 Nov;184(5):541-53 [984923.001]
  • [Cites] Am J Surg. 1978 Jul;136(1):107-12 [567016.001]
  • [Cites] Cancer. 1979 Mar;43(3):810-20 [427722.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):650-4 [16785411.001]
  • [Cites] Vestn Khir Im I I Grek. 2005;164(6):48-51 [16792315.001]
  • [Cites] Am J Med. 1981 Mar;70(3):511-8 [7211893.001]
  • [Cites] Cancer. 1985 Feb 15;55(4):794-804 [3967174.001]
  • [Cites] Surgery. 1985 Dec;98(6):1171-8 [4071392.001]
  • [Cites] Cancer. 1986 Apr 1;57(7):1405-14 [3948123.001]
  • [Cites] Mayo Clin Proc. 1986 Dec;61(12):978-96 [3773569.001]
  • [Cites] Surg Clin North Am. 1987 Apr;67(2):251-61 [3551147.001]
  • [Cites] Am J Surg. 1990 Oct;160(4):344-7 [2221232.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1991 Jun;117(6):601-5 [2036180.001]
  • [Cites] Folia Med (Plovdiv). 2006;48(1):17-22 [16918050.001]
  • [Cites] Laryngoscope. 2006 Nov;116(11):2081-5 [17075398.001]
  • [Cites] J Surg Oncol. 2006 Dec 15;94(8):683-91 [17131422.001]
  • [Cites] Ann Ital Chir. 2006 Mar-Apr;77(2):107-13 [17147082.001]
  • [Cites] Head Neck. 1996 Mar-Apr;18(2):127-32 [8647677.001]
  • (PMID = 20463835.001).
  • [ISSN] 1827-675X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2868202
  • [Keywords] NOTNLM ; Extra-capsular spread / Nodal metastases / Thyroid carcinoma
  •  go-up   go-down


38. Varandas VM, Coelho SM, Soeiro AP, Coeli CM, Carvalho DP, Buescu A, Vaisman M: [Clinical repercussion of the 6th edition TNM staging system classification on differentiated thyroid carcinoma]. Arq Bras Endocrinol Metabol; 2007 Jul;51(5):825-31
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical repercussion of the 6th edition TNM staging system classification on differentiated thyroid carcinoma].
  • The TNM classification of UICC is used for predicting the outcome of thyroid cancer.
  • Sixty-nine patients had papillary carcinoma, 14 follicular, 4 Hürthle cell, and 3 mixed.
  • For the stage IV there was a significant change in remission, however there was no difference comparing IV and IV C.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Carcinoma, Papillary / pathology. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17891247.001).
  • [ISSN] 0004-2730
  • [Journal-full-title] Arquivos brasileiros de endocrinologia e metabologia
  • [ISO-abbreviation] Arq Bras Endocrinol Metabol
  • [Language] por
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


39. Niedźwiecki S, Stepień T, Kuzdak K, Stepień H, Krupiński R, Seehofer D, Rayes N, Ulrich F: Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients. Langenbecks Arch Surg; 2008 May;393(3):275-80
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.
  • Therefore, we performed a prospective study, analyzing IL-1ra in thyroid cancer patients.
  • MATERIALS AND METHODS: We measured preoperative IL-1ra serum levels of 52 consecutive patients with thyroid cancer, 15 with benign adenoma and 27 healthy volunteers.
  • The final histological diagnosis revealed 21 patients with papillary and 8 patients with follicular carcinoma (FTC), while 12 cases of medullary and 11 cases of anaplastic carcinoma (ATC) were observed.
  • Except for the stage IV disease in ATC, there was no correlation between IL-1ra levels and International Union Against Cancer staging.
  • Future efforts should focus on the possible application of IL-1ra as a biomarker for the above-mentioned thyroid malignancies.
  • [MeSH-major] Biomarkers, Tumor / blood. Interleukin 1 Receptor Antagonist Protein / blood. Thyroid Neoplasms / blood
  • [MeSH-minor] Adenocarcinoma, Follicular / blood. Adenocarcinoma, Follicular / surgery. Adenocarcinoma, Papillary / blood. Adenocarcinoma, Papillary / surgery. Adenoma / blood. Adenoma / surgery. Adult. Aged. Carcinoma / blood. Carcinoma / surgery. Carcinoma, Medullary / blood. Carcinoma, Medullary / surgery. Female. Humans. Male. Middle Aged. Reference Values. Sex Factors. Young Adult

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Langenbecks Arch Surg. 2009 Mar;394(2):401-2; author reply 403 [18825404.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11008-13 [8855299.001]
  • [Cites] Lancet. 1987 Nov 28;2(8570):1240-2 [2890857.001]
  • [Cites] Breast Cancer Res Treat. 2006 Mar;96(2):197-202 [16319982.001]
  • [Cites] Ann Oncol. 2003 Oct;14(10):1501-4 [14504049.001]
  • [Cites] Am J Med. 1990 Nov;89(5):621-9 [2239982.001]
  • [Cites] J Immunol. 1991 Dec 15;147(12):4218-23 [1836481.001]
  • [Cites] Am J Pathol. 1993 Sep;143(3):794-803 [8362978.001]
  • [Cites] Br J Obstet Gynaecol. 1997 Dec;104(12):1407-8 [9422021.001]
  • [Cites] J Am Coll Surg. 1994 Feb;178(2):132-8 [8173722.001]
  • [Cites] Scand J Gastroenterol. 1999 Nov;34(11):1139-43 [10582766.001]
  • [Cites] Int J Cancer. 1997 Jun 11;71(6):1066-76 [9185713.001]
  • [Cites] Am J Pathol. 1992 Feb;140(2):269-75 [1531398.001]
  • [Cites] Cancer Lett. 1999 Aug 3;142(2):179-84 [10463774.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2007 Apr;292(4):R1667-74 [17138728.001]
  • [Cites] J Int Med Res. 2007 May-Jun;35(3):395-405 [17593869.001]
  • [Cites] J Biol Chem. 1991 Jun 5;266(16):10331-6 [1828071.001]
  • [Cites] Blood. 1992 May 1;79(9):2196-200 [1533321.001]
  • [Cites] Blood. 1991 Apr 15;77(8):1627-52 [1826616.001]
  • [Cites] Blood. 1994 Apr 1;83(7):1738-43 [7908231.001]
  • [Cites] Arthritis Rheum. 1995 Aug;38(8):1055-9 [7639800.001]
  • [Cites] J Exp Med. 1999 Jun 21;189(12):1863-74 [10377182.001]
  • [Cites] Annu Rev Immunol. 1998;16:27-55 [9597123.001]
  • [Cites] J Clin Invest. 1997 Jun 15;99(12):2930-40 [9185517.001]
  • [Cites] Eur J Cardiothorac Surg. 2007 Apr;31(4):719-24 [17317198.001]
  • [Cites] Gynecol Oncol. 1991 Aug;42(2):161-4 [1832651.001]
  • [Cites] Scand J Immunol. 1998 Mar;47(3):195-8 [9519856.001]
  • [Cites] J Soc Gynecol Investig. 2002 Nov-Dec;9(6):386-90 [12445604.001]
  • [Cites] J Clin Oncol. 2005 Apr 1;23(10):2339-45 [15800325.001]
  • [Cites] J Immunol. 1993 May 1;150(9):4008-18 [8473746.001]
  • [Cites] Clin Infect Dis. 2002 Jan 15;34(2):204-9 [11740709.001]
  • [Cites] Eur Cytokine Netw. 1994 Nov-Dec;5(6):517-31 [7727685.001]
  • [Cites] Br J Cancer. 2005 Aug 22;93(4):493-7 [16106254.001]
  • [Cites] Prog Growth Factor Res. 1990;2(4):193-205 [2151936.001]
  • [Cites] Blood. 1996 Apr 15;87(8):3282-8 [8605344.001]
  • [Cites] Clin Exp Immunol. 1995 Feb;99(2):303-10 [7851026.001]
  • [Cites] Gastric Cancer. 2006;9(4):284-90 [17235630.001]
  • [Cites] Int J Oncol. 1999 Dec;15(6):1251-4 [10568836.001]
  • [Cites] Lancet. 1992 Oct 17;340(8825):968 [1357359.001]
  • [Cites] Pharmacol Res. 2007 Feb;55(2):131-8 [17174563.001]
  • [Cites] Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):387-9 [17426001.001]
  • [Cites] Arthritis Rheum. 1994 Dec;37(12):1744-51 [7986220.001]
  • (PMID = 18064485.001).
  • [ISSN] 1435-2451
  • [Journal-full-title] Langenbeck's archives of surgery
  • [ISO-abbreviation] Langenbecks Arch Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / IL1RN protein, human; 0 / Interleukin 1 Receptor Antagonist Protein
  •  go-up   go-down


40. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI: Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid; 2006 Dec;16(12):1229-42
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
  • This analysis was performed to determine the effect of initial therapy on the outcomes of thyroid cancer patients.
  • Patients were stratified as low risk (stages I and II) or high risk (stages III and IV).
  • Treatments employed included near-total thyroidectomy, administration of radioactive iodine, and thyroid hormone suppression therapy.
  • Near-total thyroidectomy, radioactive iodine, and aggressive thyroid hormone suppression therapy were each independently associated with longer overall survival in high-risk patients.
  • Near-total thyroidectomy followed by radioactive iodine therapy, and moderate thyroid hormone suppression therapy, both predicted improved overall survival in stage II patients.
  • No treatment modality, including lack of radioactive iodine, was associated with altered survival in stage I patients.
  • We also conclude that radioactive iodine therapy is beneficial for stage II, III, and IV patients.
  • Importantly, we show for the first time that superior outcomes are associated with aggressive thyroid hormone suppression therapy in high-risk patients, but are achieved with modest suppression in stage II patients.
  • We were unable to show any impact, positive or negative, of specific therapies in stage I patients.
  • [MeSH-major] Carcinoma, Papillary / therapy. Thyroid Neoplasms / therapy
  • [MeSH-minor] Adenocarcinoma, Follicular / therapy. Adult. Antithyroid Agents / therapeutic use. Cohort Studies. Female. Humans. Iodine Radioisotopes / therapeutic use. Male. Middle Aged. Neoplasm Staging. Prospective Studies. Registries. Risk. Survival Analysis. Thyroidectomy. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Thyroid. 2007 Jun;17(6):595-6; author reply 596-7 [17614785.001]
  • (PMID = 17199433.001).
  • [ISSN] 1050-7256
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / K23 RR16524
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antithyroid Agents; 0 / Iodine Radioisotopes
  •  go-up   go-down


41. Lundgren CI, Hall P, Dickman PW, Zedenius J: Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer; 2006 Feb 1;106(3):524-31
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
  • BACKGROUND: Different scoring systems currently are being used to stratify patients with differentiated thyroid carcinoma (DTC) into risk groups.
  • DTC is usually subdivided into papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC).
  • Patients with TNM Stage IV disease had a higher mortality rate compared with patients with Stage II disease (odds ratio [OR]=9.1; 95% confidence interval [95% CI], 5.7-14.6).
  • Incomplete surgical excision was associated with higher mortality, particularly in patients with Stage I disease.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Carcinoma, Papillary / pathology. Neoplasm Staging / standards. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 American Cancer Society.
  • (PMID = 16369995.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


42. Kłubo-Gwieździńska J, Junik R: [The early treatment results of well differentiated thyroid cancer and its dependence on chosen factors]. Endokrynol Pol; 2008 Mar-Apr;59(2):123-30
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The early treatment results of well differentiated thyroid cancer and its dependence on chosen factors].
  • INTRODUCTION: The aim of the study was to estimate the influence of a thyroid remnants' volume, postsurgical concentration of thyroglobulin and radioiodine dose on the early treatment efficacy of well differentiated thyroid cancer.
  • MATERIAL AND METHODS: We retrospectively analyzed 91 patients (76 females, 15 men) with well differentiated thyroid cancer.
  • RESULTS: Histological classification revealed 68.1% (62/91) papillary thyroid cancers, 25.3% (23/91) follicular thyroid cancers, and 6.6% (6/91) oxyphilic thyroid cancers.
  • Among the group, 74 (81.3%) patients reached the remission criteria and the remaining 17 patients (18.7%) showed biochemical and morphological evidence of metastatic disease.
  • The remission was obtained in 100% of patients in stage I of the disease, 68.4% - in stage II, 78.6% - in stage III and 33.3% in stage IV.
  • CONCLUSIONS: Early treatment results of well differentiated thyroid cancer depend on the clinical stage, and postoperative serum thyroglobulin level measured after endogenous TSH stimulation.
  • Early treatment results are not dependent on age, sex, histological type of thyroid cancer, the dose of radioiodine used in brackets of 60-150 mCi and additional diseases.
  • [MeSH-major] Adenocarcinoma, Follicular / therapy. Carcinoma, Papillary / therapy. Thyroid Neoplasms / therapy

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • Hazardous Substances Data Bank. LEVOTHYROXINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18465687.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Iodine Radioisotopes; 9010-34-8 / Thyroglobulin; Q51BO43MG4 / Thyroxine
  •  go-up   go-down


43. Scurry WC, Lamarre E, Stack B: Radioguided neck dissection in recurrent metastatic papillary thyroid carcinoma. Am J Otolaryngol; 2006 Jan-Feb;27(1):61-3
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radioguided neck dissection in recurrent metastatic papillary thyroid carcinoma.
  • Although radioguided surgery has been used for the excision of sentinel nodes in breast cancer and melanoma, sparse literature exists describing its use in thyroid cancer.
  • We report a 69-year-old patient with a previous total thyroidectomy and lymph node dissection for papillary carcinoma who was subsequently found to have recurrent metastatic disease.
  • Our case report seeks to demonstrate a recent example of our use of the gamma-probe in radioguided surgical excision of recurrent metastatic papillary thyroid carcinoma.
  • [MeSH-major] Adenocarcinoma, Papillary / secondary. Adenocarcinoma, Papillary / surgery. Lymph Node Excision / methods. Neck Dissection / methods. Neoplasm Recurrence, Local / radionuclide imaging. Neoplasm Recurrence, Local / surgery. Thyroid Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16360827.001).
  • [ISSN] 0196-0709
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes
  •  go-up   go-down


44. Valsamaki P, Gotzamani-Psarrakou A, Tsiouris S, Molyvda-Athanasopoulou E, Psarrakos K, Papantoniou V, Gerali S, Zerva C: Tc-99m depreotide imaging of I-131-negative recurrent metastatic papillary thyroid carcinoma. Int J Cancer; 2006 Aug 15;119(4):968-70
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tc-99m depreotide imaging of I-131-negative recurrent metastatic papillary thyroid carcinoma.
  • The detection of radioiodine (I-131)-negative metastases of differentiated thyroid carcinoma (DTC) has been hitherto successfully tried by the well-known synthetic somatostatin analogue indium-111-labeled DTPA-octreotide (In-111 pentetreotide).
  • The objective of this study was to evaluate the usefulness of scintiscan with the newer synthetic somatostatin analogue Tc-99m depreotide, in the restaging of papillary thyroid carcinoma (PTC) with detectable serum thyroglobulin (Tg) levels and negative I-131 whole-body scan (WBS).
  • Whole-body planar and cervico-thoracic tomographic scintigraphy (single-photon emission tomography-SPET) with Tc-99m depreotide was performed in a 68-year-old male patient suffering from PTC stage III, with a mild increase in serum Tg levels coupled with a recent negative I-131 WBS.
  • Histopathology established the diagnosis of metastatic cervical lymph node PTC.
  • [MeSH-major] Carcinoma, Papillary, Follicular / diagnosis. Iodine Radioisotopes. Organotechnetium Compounds. Somatostatin / analogs & derivatives. Thyroid Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16550594.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes; 0 / Organotechnetium Compounds; 51110-01-1 / Somatostatin; 9M48M2SF02 / technetium Tc 99m depreotide
  •  go-up   go-down


45. Koo JS, Kwak JY, Jung W, Hong S: Importance of foamy macrophages only in fine needle aspirates to cytologic diagnostic accuracy of cystic metastatic papillary thyroid carcinoma. Acta Cytol; 2010 May-Jun;54(3):249-54
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Importance of foamy macrophages only in fine needle aspirates to cytologic diagnostic accuracy of cystic metastatic papillary thyroid carcinoma.
  • OBJECTIVE: To investigate the important cytologic features and thyroglobulin (Tg) level in fine needle aspiration cytology (FNAC) of cystic metastasis of papillary thyroid carcinoma (PTC) and to find some independent cytologic factors that enhance the diagnostic accuracy of cystic lymph node metastasis without identifiable tumor cells or high levels of Tg.
  • CONCLUSION: Foamy macrophages only without Tg level information in FNAC could raise the possibility of cystic metastatic PTC even if no identifiable tumor cells are found.
  • [MeSH-major] Adenocarcinoma, Papillary / secondary. Foam Cells / pathology. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20518406.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 9010-34-8 / Thyroglobulin
  •  go-up   go-down


46. Chuang WY, Yeh CJ, Chu PH, Liao CC, Wu CT, Chuang CC, Pai PC, Tseng CK, Jung SM, Wei KC, Chang CN: Expression of thyroid transcription factor-1 in brain metastases: a useful indicator of pulmonary origin. J Clin Neurosci; 2008 Jun;15(6):643-6
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of thyroid transcription factor-1 in brain metastases: a useful indicator of pulmonary origin.
  • Thyroid transcription factor-1 (TTF-1) is a marker commonly expressed in lung and thyroid carcinomas.
  • Forty-three consecutive patients metastatic carcinomas of the brain were reviewed from a 4 year period.
  • Twenty-one (75%) of the 28 metastatic pulmonary carcinomas were TTF-1 positive (+), whereas only one metastatic papillary thyroid carcinoma (7%) out of 15 metastatic non-pulmonary carcinomas was TTF-1 (+).
  • [MeSH-major] Brain Neoplasms / metabolism. Brain Neoplasms / secondary. Carcinoma / metabolism. Carcinoma / secondary. Lung Neoplasms / pathology. Nuclear Proteins / metabolism. Transcription Factors / metabolism

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18413286.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Cytokines; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / thyroid nuclear factor 1
  •  go-up   go-down


47. Shpitzer T, Saute M, Gilat H, Raveh E, Koren I, Shvero J, Bahar G, Feinmesser R: Adaptation of median partial sternotomy in head and neck surgery. Am Surg; 2007 Dec;73(12):1275-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The 17 patients included 11 adults with metastatic thyroid disease (six metastatic papillary thyroid carcinoma, two medullary carcinoma, and one Hiirthle cell carcinoma) and huge retrosternal goiter (n = 2), four adults with parathyroid disease (two primary parathyroid adenoma, one secondary hyperplasia, and one parathyroid carcinoma), and two children with lymphangioma and huge thymic cyst (one each).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18186389.001).
  • [ISSN] 0003-1348
  • [Journal-full-title] The American surgeon
  • [ISO-abbreviation] Am Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Sheahan P, Hafidh M, Toner M, Timon C: Unexpected findings in neck dissection for squamous cell carcinoma: incidence and implications. Head Neck; 2005 Jan;27(1):28-35
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unexpected findings in neck dissection for squamous cell carcinoma: incidence and implications.
  • These pathologic findings may simulate malignant disease and/or have implications on the already complicated management of patients with head and neck cancer.
  • METHODS: We retrospectively reviewed 202 consecutive patients with a preoperative diagnosis of squamous cell carcinoma (SCC), who underwent 307 neck dissections performed by a single surgeon and examined by a single pathologist.
  • These included metastatic papillary thyroid carcinoma, leukemia, lymphoma, Warthin's tumor, and tuberculosis.
  • Two of three patients with benign-appearing thyroid tissue within lymph nodes received no further treatment, and both remained well beyond 6 years.
  • [MeSH-major] Carcinoma, Squamous Cell / surgery. Head and Neck Neoplasms / surgery. Neck Dissection
  • [MeSH-minor] Adenolymphoma / pathology. Adenolymphoma / therapy. Aged. Aged, 80 and over. Carcinoma, Papillary / pathology. Carcinoma, Papillary / secondary. Carcinoma, Papillary / surgery. Cricoid Cartilage / pathology. Female. Humans. Leukemia, Lymphocytic, Chronic, B-Cell / pathology. Leukemia, Lymphocytic, Chronic, B-Cell / therapy. Lymphatic Metastasis. Lymphoma, B-Cell / pathology. Lymphoma, B-Cell / therapy. Male. Middle Aged. Retrospective Studies. Thyroid Neoplasms / pathology. Thyroid Neoplasms / secondary. Thyroid Neoplasms / surgery. Thyroidectomy. Tuberculosis, Lymph Node / drug therapy. Tuberculosis, Lymph Node / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2004 Wiley Periodicals, Inc.
  • (PMID = 15459919.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Paraskeva M, McLean C, Snell GI, Westall GP: Lung transplant survival despite unexpected pulmonary metastatic thyroid cancer in the explant. Transpl Int; 2010 Sep;23(9):e45-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lung transplant survival despite unexpected pulmonary metastatic thyroid cancer in the explant.
  • We describe a 15- year-old patient who underwent cut-down lobar lung transplant for end-stage obliterative bronchiolitis secondary to GVHD that had developed as a result of haematopoietic stem cell transplantation for childhood acute lymphoblastic leukaemia.
  • Unexpectedly, histopathological examination of the explant revealed extensive metastatic papillary thyroid cancer.
  • [MeSH-major] Carcinoma, Papillary / secondary. Graft Survival. Lung Neoplasms / secondary. Lung Transplantation / methods. Thyroid Neoplasms / pathology


50. Choi JY, Kim JH: A case of an ectopic thyroid gland at the lateral neck masquerading as a metastatic papillary thyroid carcinoma. J Korean Med Sci; 2008 Jun;23(3):548-50
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of an ectopic thyroid gland at the lateral neck masquerading as a metastatic papillary thyroid carcinoma.
  • Ectopic thyroid glands generally occur in the midline as a result of abnormal median migration, and their presence lateral to the midline is rare.
  • We present one case of an ectopic thyroid gland masquerading as a lateral neck metastasis of a papillary thyroid carcinoma (PTC).
  • The patient was diagnosed as having an accessory thyroid gland on the lateral neck on the final pathologic report.
  • Surgeons should be aware of the existence of an ectopic thyroid gland in unusual locations.
  • [MeSH-major] Carcinoma, Papillary / secondary. Choristoma / pathology. Thyroid Gland. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 2001 Jan;86(1):392-5 [11232030.001]
  • [Cites] Clin Nucl Med. 2001 Apr;26(4):306-9 [11290889.001]
  • [Cites] Clin Nucl Med. 2001 Nov;26(11):933-5 [11595847.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Oct;128(10):1198-200 [12365894.001]
  • [Cites] Otolaryngol Head Neck Surg. 2005 May;132(5):806-8 [15886641.001]
  • [Cites] Otolaryngol Head Neck Surg. 2004 May;130(5):630-2 [15138431.001]
  • [Cites] Arch Intern Med. 1987 Nov;147(11):2046-8 [3675109.001]
  • [Cites] Surg Clin North Am. 1993 Aug;73(4):727-46 [8378818.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Dec;84(6):697-702 [9431542.001]
  • [Cites] J Vasc Surg. 2004 Jan;39(1):260-2 [14718850.001]
  • (PMID = 18583899.001).
  • [ISSN] 1011-8934
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2526509
  •  go-up   go-down


51. Lee MJ, Kim EK, Kim MJ, Kwak JY, Hong S, Park CS: Spontaneous pneumothorax in metastatic thyroid papillary carcinoma. J Clin Oncol; 2007 Jun 20;25(18):2616-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous pneumothorax in metastatic thyroid papillary carcinoma.
  • [MeSH-major] Adenocarcinoma, Papillary / complications. Lung Neoplasms / secondary. Pneumothorax / etiology. Thyroid Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Collapsed Lung.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17577042.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


52. Manganaris C, Wittlin S, Xu H, Gurell M, Sime P, Kottmann RM: Metastatic papillary thyroid carcinoma and severe airflow obstruction. Chest; 2010 Sep;138(3):738-42
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic papillary thyroid carcinoma and severe airflow obstruction.

  • MedlinePlus Health Information. consumer health - Choking.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 1999 Nov;84(11):4043-9 [10566647.001]
  • [Cites] AJR Am J Roentgenol. 2008 Nov;191(5):1570-5 [18941103.001]
  • [Cites] Radiology. 2001 Mar;218(3):695-702 [11230642.001]
  • [Cites] Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Dec;14(4):601-13 [11289737.001]
  • [Cites] Lancet. 2003 Feb 8;361(9356):501-11 [12583960.001]
  • [Cites] J Nucl Med. 2003 Mar;44(3):451-6 [12621014.001]
  • [Cites] Cancer. 1988 Jan 1;61(1):1-6 [3334935.001]
  • [Cites] J Laryngol Otol. 1993 Aug;107(8):752-4 [8409736.001]
  • [Cites] Radiographics. 1994 Sep;14(5):991-1003 [7991828.001]
  • [Cites] Radiology. 1997 May;203(2):361-7 [9114089.001]
  • [Cites] Otolaryngol Head Neck Surg. 1997 Dec;117(6):S117-20 [9419122.001]
  • [Cites] Thyroid. 2006 Feb;16(2):109-42 [16420177.001]
  • [Cites] Thorax. 2006 Sep;61(9):799-804 [16670170.001]
  • [Cites] Thyroid. 2007 Apr;17(4):367-9 [17465869.001]
  • [Cites] J Occup Environ Med. 2007 Aug;49(8):840-5 [17693781.001]
  • [Cites] Radiology. 2000 Mar;214(3):831-6 [10715053.001]
  • (PMID = 20822998.001).
  • [ISSN] 1931-3543
  • [Journal-full-title] Chest
  • [ISO-abbreviation] Chest
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL075432; United States / NHLBI NIH HHS / HL / T32 HL066988; United States / NHLBI NIH HHS / HL / R01 HL75432; United States / NHLBI NIH HHS / HL / T32 HL66988
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2950112
  •  go-up   go-down


53. Roscoe KJ, Raja S, Tronic B, Dou Y: Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer. Clin Nucl Med; 2006 Jun;31(6):359-60
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenocarcinoma, Papillary / radionuclide imaging. Adenocarcinoma, Papillary / secondary. Fluorodeoxyglucose F18. Lung Neoplasms / radionuclide imaging. Thyroid Neoplasms / radionuclide imaging. Thyroid Neoplasms / secondary


54. Gupta R, Viswanathan S, D'Cruz A, Kane SV: Metastatic papillary carcinoma of thyroid masquerading as a renal tumour. J Clin Pathol; 2008 Jan;61(1):143
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic papillary carcinoma of thyroid masquerading as a renal tumour.
  • [MeSH-major] Carcinoma, Papillary / secondary. Kidney Neoplasms / secondary. Thyroid Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18156435.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  •  go-up   go-down


55. Grosz AH, Sauer DA, Bliziotes MM, Cohen JI, Gross ND: Metastatic papillary thyroid carcinoma presenting as a long-standing calcified neck mass. Thyroid; 2007 Aug;17(8):799-800
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic papillary thyroid carcinoma presenting as a long-standing calcified neck mass.
  • [MeSH-major] Calcinosis / etiology. Carcinoma, Papillary / complications. Carcinoma, Papillary / secondary. Thyroid Neoplasms / complications. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17725440.001).
  • [ISSN] 1050-7256
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement